This article presents a novel exposure apparatus that allows the exposure o
f cultured cells to volatile chemicals, e.g., inhalation anesthetics. The a
pparatus consists of an exposure chamber and a tightly linked vaporizer uni
t with pumps and valves allowing adjustable fluxes of mixtures of test chem
icals and carrier gas under open and closed-circuit conditions. The exposur
e chamber uses commercially available cell culture flasks and accommodates
up to 12 flasks simultaneously. Both modules fit into a standard culture in
cubator. The exposure chamber may be mounted onto an oscillating axis to ti
lt the cultures periodically forth and back, thus allowing direct contact o
f the cells with test atmosphere. The vaporizer unit is connected to a pers
onal computer which lets the experimenter set the "open" and "close" interv
als of individual valves thereby controlling the composition and now rate o
f the test gas mixture. The vapor concentration of test chemicals can be mo
nitored at the inlet and outlet using infrared photodetectors or mass spect
rometers. Computer-aided processing of exposure protocols allows unattended
runs. Exposure protocols can be scripted and stored on disk, thus ensuring
interexperimental reproducibility of complex exposure profiles. As an appl
ication example, the effect of three volatile anesthetics, halothane, enflu
rane, and isoflurane, on the viability of three commercially available cell
lines (A549-human lung carcinoma, HTC-rat hepatoma, MDCK-Madin-Darby canin
e kidney) was investigated. After exposure to haloalkyl vapors (3%) for 6 a
nd 24 h, respectively, significantly increased LDH levels versus controls,
indicating cellular membrane damage, were detected in A549 and hepatoma cel
ls after exposure for 24 h. Hepatoma cells showed a significant LDH release
also after 6 h exposure to isoflurane. On the other hand, LDH release from
MDCK cells was not significantly different from controls even after 24 h o
f continuous exposure to any of the tested anesthetics. (C) 1999 Elsevier S
cience Inc.